Screening for chlamydia with the Pap test

The implementation of the recent National Health and Medical Research Council Guidelines for the management of asymptomatic women with screen detected abnormalities is welcome and should address the current practice of unnecessary repeated investigation of young women infected with human papilloma virus (HPV). It is timely to consider the overall benefit of the Pap test in this group for whom rates of cervical cancer are extremely low.